These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3568043)

  • 1. [Phosphocreatine in the protection of the myocardium in cardioplegic arrest; biochemical and functional aspects in the dog].
    Bricco G; Piacenza G; Borgoglio R; Zamperone O; Sguazzi P
    Cardiologia; 1986 Jul; 31(7):509-14. PubMed ID: 3568043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Creatine phosphate: an additive to cardioplegic solutions. Clinical study].
    D'Alessandro LC; Cini R; Stazi G; Pucci A; De Benedictis F; Rabitti G; Benhar M; Giacopino F; Pezza E; Cioli G
    Cardiologia; 1987 Mar; 32(3):307-13. PubMed ID: 3607801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the protective effect of phosphocreatine on the ischemic myocardium during cardioplegia using the P-31 NMR method].
    Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Ruuge EK; Kapel'ko VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):14-9. PubMed ID: 4005052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog.
    Rosenfeldt FL; Hearse DJ; Canković-Darracott S; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):29-38. PubMed ID: 7350386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioplegic hemoglobin perfusion: a method of providing optimal myocardial protection.
    Elert O; Ottermann U
    Thorac Cardiovasc Surg; 1979 Aug; 27(4):245-7. PubMed ID: 162775
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of phosphocreatine on the myocardium (experimental study)].
    Afonskaia NI; Sharov VG; Ruda MIa; Vikhert AM; Cherpachenko NM
    Vestn Akad Med Nauk SSSR; 1986; (12):50-8. PubMed ID: 3825276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical changes in the myocardium after chemical cardioplegia and hypothermia].
    Furman M; Adamski S; Głowiński S; Witkowski S; Laudanski J; Ostapowicz J; Gacko M; Bernacki A; Worowska A
    Kardiol Pol; 1983; 26(3):253-9. PubMed ID: 6632496
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between myocardial temperature and recovery after experimental cardioplegic arrest.
    Rosenfeldt FL
    J Thorac Cardiovasc Surg; 1982 Nov; 84(5):656-66. PubMed ID: 7132405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of crystalloid and sanguineous cardioplegic solutions in the dog.
    Spackman CJ; Caywood DD; Gannon PG; Irmiter RA; Louis CF
    Am J Vet Res; 1985 Jun; 46(6):1330-4. PubMed ID: 4026010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The superiority of blood cardioplegia in myocardial preservation.
    Engelman RM; Rousou JH; Dobbs W; Pels MA; Longo F
    Circulation; 1980 Aug; 62(2 Pt 2):I62-6. PubMed ID: 7397998
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium-induced ventricular contraction during cardioplegic arrest.
    Torchiana DF; Love TR; Hendren WG; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):606-13. PubMed ID: 3657262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the pH of cardioplegic solution on postarrest myocardial preservation.
    Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ
    Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine phosphate: a critical variable in assessing metabolic activity during cardioplegic arrest.
    Ellis RJ; Gardner CP
    Surg Forum; 1979; 30():243-5. PubMed ID: 538609
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies.
    Sharov VG; Saks VA; Kupriyanov VV; Lakomkin VL; Kapelko VI; Steinschneider AYa ; Javadov SA
    J Thorac Cardiovasc Surg; 1987 Nov; 94(5):749-61. PubMed ID: 3669703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improving the contractility and metabolism of the isolated rat heart during post-ischemia reperfusion with phosphocreatine, tocopheryl phosphate and their combination].
    Konorev EA; Saks Va; Sharov VG; Evstigneeva RP
    Vestn Akad Med Nauk SSSR; 1989; (12):55-63. PubMed ID: 2629378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of reperfusional damage from ischemic myocardium.
    Kao RL; Magovern GJ
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):106-14. PubMed ID: 3941553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent protection provided by red blood cells during cardioplegia.
    Bing OH; LaRaia PJ; Gaasch WH; Spadaro J; Franklin A; Weintraub RM
    Circulation; 1982 Aug; 66(2 Pt 2):I81-4. PubMed ID: 7083551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.